Regional
Australia
Hong Kong
Malaysia
Taiwan
Pakistan
Philippines
Singapore
Thailand
VietnamPancreatic Stone Protein Measurement to Screen and Diagnose Sepsis in the Context of the Surviving Sepsis Campaign Recommendations.
Published on July 3, 2024
Sepsis affects 48.9 million annually, leading to 11 million deaths worldwide. While current guidelines provide essential recommendations, they often lack clear clinical direction, particularly in screening high-risk patients for nosocomial sepsis. This study highlights the potential of biomarkers like pancreatic stone protein (PSP) to improve diagnostic accuracy and guide effective treatment amidst rising challenges in antibiotic resistance and healthcare costs. Read more here.
Getz Healthcare is proud to be recognized as the leading distributor of medical equipment, devices and consumables, in Asia Pacific.
Our full-service distribution capabilities provide end-to-end representation of our business partners’ products, while delivering comprehensive service and solutions to our customers in all the countries we serve. Learn more
All product information listed on this site are for healthcare professionals only. Descriptions and specifications of the products listed on this site are provided by the manufacturer.